You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 5, May 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reserpine-Digitalis Toxicity

Case Reports of Cardiac Arrhythmias Occurring During Reserpine-Digitalis Therapy and a Review of the Literature with Supporting Animal Experiments

H. LENOX H. DICK, M.D.; ELTON L. McCAWLEY, M.S., Ph.D.; WILLIAM A. FISHER, M.D.

Arch Intern Med. 1962;109(5):503-506.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Reserpine and digitalis are often given to the same patient when arterial hypertension and congestive heart failure occur at the same time. Reserpine's reduction of peripheral resistance and bradycrotic effect may assist the digitalis compensation of congestive heart failure.1 Reserpine has also been found useful in slowing the tachycardia of thyrotoxicosis. Marangoni and Cavusoglu2 reported that for certain patients with atrial fibrillation and a rapid ventricular rate reserpine may substitute for digitalis.

Reserpine alone has been implicated as both provoking arrhythmias and reversing them, although such reports are incidental to the drug's use for other purposes. Our purpose is to describe patients with alarming cardiac arrhythmias which appeared following the simultaneous administration of digitalis and reserpine. The literature relative to reserpine and cardiac arrhythmias will be reviewed, and experiments using digitalis and reserpine in the dog will be summarized.

Report of Cases

CASE 1.—

A 35-month-old girl was . . . [Full Text PDF of this Article]


Author Affiliations

PORTLAND, ORE.

From the Department of Pharmacology, University of Oregon Medical School, Portland, Oregon. Supported by grants from the National Heart Institute, United States Public Health Service. Supplies of reserpine (Serpasil) used were made through the courtesy of Dr. Charles Sullivan, Ciba Pharmaceutical Products, Inc., Summit, N.J.


Footnotes

Submitted for publication March 7, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.